- Report
- November 2023
- 149 Pages
Asia Pacific
From €3565EUR$4,000USD£3,132GBP
- Report
- November 2023
- 178 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- November 2023
- 190 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- November 2023
- 120 Pages
Europe
From €3565EUR$4,000USD£3,132GBP
- Report
- October 2023
- 126 Pages
North America
From €3565EUR$4,000USD£3,132GBP
- Report
- August 2023
- 78 Pages
Egypt
From €3120EUR$3,500USD£2,740GBP
- Report
- August 2023
- 76 Pages
South Korea
From €3120EUR$3,500USD£2,740GBP
- Report
- December 2022
- 72 Pages
Israel
From €3120EUR$3,500USD£2,740GBP
- Report
- September 2021
- 114 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- March 2024
- 241 Pages
Global
From €3160EUR$3,545USD£2,776GBP
€3511EUR$3,939USD£3,084GBP
- Report
- July 2024
- 150 Pages
Global
From €2674EUR$3,000USD£2,349GBP
€3342EUR$3,750USD£2,936GBP
- Report
- May 2024
- 183 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- May 2024
- 83 Pages
India
From €3120EUR$3,500USD£2,740GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1426EUR$1,600USD£1,253GBP
€1783EUR$2,000USD£1,566GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1426EUR$1,600USD£1,253GBP
€1783EUR$2,000USD£1,566GBP
- Report
- February 2024
- 204 Pages
Global
From €4234EUR$4,750USD£3,719GBP
- Report
- April 2023
- 114 Pages
Global
From €4234EUR$4,750USD£3,719GBP
- Report
- April 2023
- 90 Pages
Middle East, Africa
From €4234EUR$4,750USD£3,719GBP
- Report
- September 2024
- 353 Pages
Global
From €4457EUR$5,000USD£3,915GBP
- Report
- May 2024
- 296 Pages
Global
From €4457EUR$5,000USD£3,915GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more